A topical treatment blocking the enzyme LSD1 activated immune responses in skin cells and slowed tumor growth in models of ...

A topical cream activated the skin's immune defenses and suppressed tumor growth in two preclinical models of cutaneous squamous cell carcinoma (cSCC), according to a study published in the Journal of ...

Schlesinger: For advanced cSCC, immunotherapy has been a game-changer. The first immunotherapy drugs approved in the space were PD-1 inhibitors such as cemiplimab (Libtayo; Regeneron) and ...

Comparing metagenomic profiles of the skin microbiome in immunosuppressed patients and those at high and low risk for cutaneous squamous cell carcinoma (SCC) revealed distinct expansions in fungal and ...

Registration link below for Wednesday March 18, 2026 at 4 PM EDT Phio invites individual and institutional investors, as well ...

The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...

Add Yahoo as a preferred source to see more of our stories on Google. Skin cancer is the most common cancer in the U.S., according to the Centers for Disease Control and Prevention. Between 1982 and ...

There are three common types of skin cancer in the United States: basal cell carcinoma, squamous cell carcinoma and melanoma. Merkel cell carcinoma is a rare type of skin cancer. Fred Hutch Cancer ...

Skin cancer is a type of cancer that begins in the skin cells, and its appearance can vary widely depending on the type of cancer. Understanding the variations in what skin cancer looks like can help ...

If there's one good thing about skin cancer, it's that you can spot it yourself—if you know what to look for. And the earlier you can find skin cancer, the sooner you can seek treatment. The Skin ...

Doctors say simple habits like sunscreen use, avoiding tanning beds and regular skin checks can significantly lower risk.